openPR Logo
Press release

Poland Generic Drugs Market: Trends, Drivers, and Forecast (2024-2030)

07-26-2024 01:59 PM CET | Health & Medicine

Press release from: STELLAR MARKET RESEARCH

Poland Generic Drugs Market

Poland Generic Drugs Market

Poland Generic Drugs Market was valued at USD 22.14 Bn. in 2023 and the market size is estimated USD 30.13 Bn. for 2030 to grow at a CAGR of 4.5 percent as per Stellar Market Research. The report is a combination of primary data and secondary data and field experts have examined the Poland Generic Drugs Market.

Click Here for Additional Details Regarding the Report https://www.stellarmr.com/report/Poland-Generic-Drugs-Market/1795

Poland Generic Drugs Market Overview:

The Poland generic drugs market is considered by the presence of generic drugs that contain the same active ingredients and strength as brand-name drugs. After the patent on a new drug expires generic versions become available offering cost-effective alternatives. Companies are categorized based on their market focus and strength, and factors such as the negotiating power of buyers and suppliers, and the threat of new entrants, rivalry, and substitutes are analyzed to assess market favorability.

The market is driven by patent expirations of blockbuster drugs, rising demand for cost-effective therapies, and governing initiatives promoting generic competition and innovation. Poland supports its domestic pharma industry to address rising production costs and compete with Asia, and is excited about proposed amendments to European pharmaceutical regulation.

Poland Generic Drugs Market Dynamics:

The dynamics of the Poland generic drugs market are influenced by regulatory shifts and economic viability. Increased regulations, such as pricing regulations included in the reimbursement system, have pushed market growth. The rising cost of branded medicine is increased healthcare expenditure, and demand for generic drugs have driven market growth. Manufacturers are investing in enhanced generic drugs, and the economic viability of the market is supported by the positive attitude of physicians towards generic medicines and high patient co-payments.

The market faces challenges such as drug shortages due to national price caps, limited access to healthcare infrastructure, insufficient healthcare facilities, lack of trained personnel, and inadequate distribution of generic drugs. . Economic disparities also contribute to financial constraints on both the government and the population. The inflation rate in Poland was 14.4% in 2023, affecting the cost of medicines. The oral segment holds a significant market share due to its safety and cost-effectiveness, while the hospital segment dominates due to the increasing adoption of generic drugs by community pharmacies.

For additional details: To receive a Free Sample Report :https://www.stellarmr.com/report/req_sample/Poland-Generic-Drugs-Market/1795
Poland Generic Drugs Market Scope:

Market Size in 2023 USD 22.14 Bn.

Market Size in 2030 USD 30.13 Bn.

CAGR 4.5% (2024-2030)

Forecast Period 2024-2030

Base Year 2023

Number of Pages 255

No. of Tables 120

No. of Charts and Figures 115

Segment Covered by Type, Application, Route of Administration, and End User

Report Coverage Poland Generic Drugs Market Share, Size & Forecast by Revenue | 2024-2030, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, SMR Competition Matrix, Competitive Leadership Mapping, Global Key Players' Market Ranking Analysis.

Poland Generic Drugs Market Segmentation:

By Type

Simple Generics

Super Generics

By Application

Central Nervous System (CNS)

Cardiovascular

Dermatology

Oncology

Respiratory

Others

By Route of Administration

Oral

Topical

Parenteral

Others

By End User

Hospitals

Homecare

Specialty Clinics

Others

For additional details: To receive a Free Sample Report :https://www.stellarmr.com/report/req_sample/Poland-Generic-Drugs-Market/1795

Some of the current players in the Poland Generic Drugs Market are:

Polfa Tarchomin

Aflofarm

Adamed Pharma S.A.

Key questions answered in the Poland Generic Drugs Market are:

What segments are covered in the Poland Generic Drugs Market report?

How much CAGR is expected to grow in the Poland Generic Drugs Market?

What is the forecast period for the Poland Generic Drugs Market?

What was the market size of the Poland Generic Drugs Market in 2023?

Key Offerings:

Past Market Size and Competitive Landscape

Poland Generic Drugs Market Size, Share, Size & Forecast by different segment

Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region

Poland Generic Drugs Market Segmentation - A detailed analysis by Product

Competitive Landscape - Profiles of selected key players by region from a strategic perspective

Competitive landscape - Market Leaders, Market Followers, Regional player

Competitive benchmarking of key players by region

PESTLE Analysis

PORTER's analysis

Value chain and supply chain analysis

Legal Aspects of business by region

Lucrative business opportunities with SWOT analysis

Recommendations

Explore our top-performing reports on the latest trends:

US Generic Drugs Market
Mexico Generic Drugs Market
Germany Generic Drugs Market

Contact Stellar Market Research:

S.no.8, h.no. 4-8 Pl.7/4 Kothrud

Pinnac Memories Fl. No. 3

Kothrud, Pune, Maharashtra, 411029

sales@stellarmr.com

+91 9607365656

About Stellar Market Research:

Stellar Market Research is an India-based consulting and advisory firm focused on helping clients reach their business transformation objectives with advisory services and strategic business. Firm research on many topics like Healthcare, Pharmaceuticals, Electronics and communications, Chemical and Material, Food and Beverages, Aerospace, and defense, and other sectors. The company provide numerous services i.e. consultancy, Market Intelligence, Syndicate Research etc. to help executives in any organization and consumers achieve their mission-critical goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Poland Generic Drugs Market: Trends, Drivers, and Forecast (2024-2030) here

News-ID: 3600425 • Views:

More Releases from STELLAR MARKET RESEARCH

Ready to Eat (RTE) Baked Products and Bakery Premixes Market Share, Industry Growth, Business Strategy, Trends and Regional Outlook 2032
Ready to Eat (RTE) Baked Products and Bakery Premixes Market Share, Industry Gro …
Ready to Eat (RTE) Baked Products and Bakery Premixes Market was estimated at USD 154.85 Bn. in 2024 and the total revenue is projected to grow at CAGR of 7% From 2025 to 2032 reaching nearly USD 231.41 Bn. by 2032. Stellar Market Research published a report "Ready to Eat Baked Products and Bakery Premixes Market and forecast (2025-2032)." The report is a comprehensive analysis of global Ready to Eat Baked
Micromotor Market Comprehensive Research Study, Competitive Landscape and Forecast 2025-2032
Micromotor Market Comprehensive Research Study, Competitive Landscape and Foreca …
Micromotor Market was estimated at USD 43.10 Bn in 2024, and its total revenue is projected to grow at a CAGR of 7.1% from 2025 to 2032, reaching nearly USD 69.66 Bn by 2032. Stellar Market Research published a report "Micromotor Market and forecast (2025-2032)." The report is a comprehensive analysis of global Micromotor Market share, size, growth, trends, and forecast. The report also contains competitor analysis and regional analysis and
Monkeypox Vaccine and Treatment Market Sales and Revenues of Manufacturers Forecast till 2025-2032
Monkeypox Vaccine and Treatment Market Sales and Revenues of Manufacturers Forec …
Monkeypox Vaccine and Treatment Market size was estimated at USD 103.5 Mn in 2024 and the total Global Monkeypox Vaccine and Treatment revenue is projected to grow at a CAGR of 10.20% from 2025 to 2032, reaching nearly USD 225.12 Mn by 2032. Stellar Market Research published a report "Monkey pox Vaccine and Treatment Market and forecast (2025-2032)." The report is a comprehensive analysis of global monkey pox Vaccine and Treatment
K12 Education Market Dynamics, Competitive Landscape, Outlook 2025-2032
K12 Education Market Dynamics, Competitive Landscape, Outlook 2025-2032
K12 Education Market Size was valued at USD 2.65 Tn in 2024 and is projected to grow at a CAGR of 12.6% from 2025 to 2032, reaching nearly USD 6.85 Tn by 2032. Stellar Market Research has released a report "K12 Education Market and forecast (2025-2032)." The report is a detailed analysis of the global market share, size, growth, trends, and forecast of K12 Education Market. It also includes competitor and

All 5 Releases


More Releases for Generic

Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth? The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall. Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs. The global generic drugs market is driven by the rise of
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems. At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of